ERBB2 and neoplasm: Using a different vector, adenovirus constructs with extracellular domains of CEA or HER2 targeted to exosomes (via lactadherin C1C2 domain) again produced specific T cell and antibody responses, to some extent even in antigen-tolerant animal models, with subsequent improved tumor rejection in the HER2 model [104].